Revolutionary retinal implant restores central vision in 80% of patients with advanced macular degeneration, offering hope ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. | ...

WASHINGTON, DC – Indian students form a vital part of the U.S. higher education system, with nearly 269,000 enrolled in 2024, marking a 35% increase over the previous year. They are second only to ...

The system, when mounted on utility vehicles, is light enough to travel inside of a Chinook helicopter or sling-loaded under ...

Integrating a controlled-release iodine layer into hip implants could reduce the rate of potentially fatal infections.

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

The Wasteful and Inappropriate Service Reduction initiative from CMS is set to take effect Jan. 1, 2026, introducing new prior authorization requirements for select services. Here are seven things to ...

MSD has moved a step closer to completing its acquisition of Verona Pharma, after a vote in favour of the transaction by the UK company's shareholders. Investors in Verona – a specialist in ...

Our reviewer is committed to trying Noom long-term for 1 year. Noom focuses on behavioral changes, calling itself a lifestyle rather than a diet. Noom offerings include Noom Vibe, a support app with ...

Alector, Inc. announced that its experimental therapy latozinemab failed to meet primary efficacy and safety endpoints in a ...